• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Vaccine, Volume 26 - Pathology of human influenza revisited

Giuseppe

Emeritus
ScienceDirect - Vaccine, Volume 26 - Pathology of human influenza revisited

Abstract

The pathology of human influenza has been studied most intensively during the three pandemics of the last century, the last of which occurred in 1968.

It is important to revisit this subject because of the recent emergence of avian H5N1 influenza in humans as well as the threat of a new pandemic.

Uncomplicated human influenza virus infection causes transient tracheo-bronchitis, corresponding with predominant virus attachment to tracheal and bronchial epithelial cells.

The main complication is extension of viral infection to the alveoli, often with secondary bacterial infection, resulting in severe pneumonia.

Complications in extra-respiratory tissues such as encephalopathy, myocarditis, and myopathy occur occasionally.

Sensitive molecular and immunological techniques allow us to investigate whether these complications are a direct result of virus infection or an indirect result of severe pneumonia.

Human disease from avian influenza virus infections is most severe for subtype H5N1, but also has been reported for H7 and H9 subtypes.

In contrast to human influenza viruses, avian H5N1 virus attaches predominantly to alveolar and bronchiolar epithelium, corresponding with diffuse alveolar damage as the primary lesion.

Viremia and extra-respiratory complications appear to be more common for infections with avian H5N1 virus than with human influenza viruses.

Further understanding and comparison of the pathology of human and avian influenza virus infections only can be achieved by directed and careful pathological analysis of additional influenza cases.
<cite cite="http://www.sciencedirect.com/science?_ob=PublicationURL&_tockey=%23TOC%235188%232008%23999739999.8995%23697888%23FLA%23&_cdi=5188&_pubType=J&_auth=y&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=9aa2a4077daed1b96fb5cdd42d8aaf3c">ScienceDirect - Vaccine, Volume 26, Supplement 4, Pages D1-D74 (12 September 2008)</cite>
 
Back
Top